Filter Results:
(699)
Show Results For
- All HBS Web
(1,192)
- People (1)
- News (316)
- Research (699)
- Events (5)
- Multimedia (14)
- Faculty Publications (418)
Show Results For
- All HBS Web
(1,192)
- People (1)
- News (316)
- Research (699)
- Events (5)
- Multimedia (14)
- Faculty Publications (418)
Sort by
- 25 Sep 2000
- Research & Ideas
More Than the Sum of Its Parts: The Impact of Modularity on the Computer Industry
cost-effective to experiment and incorporate the results of the experimentation into the system. KB: So a modular design with, say, ten modules might justify ten or more trial designs per module. The module... View Details
- July 2009
- Teaching Note
The Miami Project to Cure Paralysis (TN)
By: Robert Steven Kaplan, Christopher Marquis and Ben Creo
Teaching Note for [408003]. View Details
- 14 Apr 2021
- Research & Ideas
The High Cost of the Slow COVID Vaccine Rollout
dollars in value, Kominers and his co-authors reported in Market Design to Accelerate COVID-19 Vaccine Supply in the March 12 issue of Science. “The value of being able to produce vaccines at scale the minute they clear View Details
- 25 Mar 2001
- Research & Ideas
Who Wants to Be an Entrepreneur? [Part II]
initial valuations accorded such an early-stage enterprise. Cash and vision in hand, they courted senior managers from Lycos, Disney, Merrill Lynch, and elsewhere to launch the... View Details
Keywords: by John S. Rosenberg
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
cause of blindness. In October 2009 the company entered into licensing and purchase option agreements with Alcon, which is now taking Potentia's drug candidate through Clinical 2 trials with a to-market goal... View Details
- September 2020
- Case
Merck: COVID-19 Vaccines
By: Willy C. Shih
COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,... View Details
Keywords: Vaccines; COVID-19 Pandemic; Health Pandemics; Health Testing and Trials; Innovation and Management; Innovation Strategy; Technological Innovation; Business Strategy; Product Launch; Pharmaceutical Industry
Shih, Willy C. "Merck: COVID-19 Vaccines." Harvard Business School Case 621-028, September 2020.
- November 2007
- Case
Antegren: A Beacon of Hope
By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann
The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details
Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Biotechnology Industry; Pharmaceutical Industry
Margolis, Joshua D., Thomas J. DeLong, and Terence Heymann. "Antegren: A Beacon of Hope." Harvard Business School Case 408-025, November 2007.
- 11 May 2020
- Op-Ed
Immigration Policies Threaten American Competitiveness
It is no secret that immigration has reshaped American innovation. Immigrants are the backbone of America’s most innovative industries, provide a quarter of our patent applications, and are numerous among our science and engineering superstars. Taken from World... View Details
Keywords: by William R. Kerr
- 2013
- Article
Planning Prompts as a Means of Increasing Preventive Screening Rates
By: Katherine L Milkman, John Beshears, James J. Choi, David Laibson and Brigitte C. Madrian
Keywords: Reminder Systems; Communication; Economics; Behavioral; Primary Prevention; Colonoscopy; Memory; Behavior; Health Care and Treatment; Health Testing and Trials; Communication Strategy; Health Industry
Milkman, Katherine L., John Beshears, James J. Choi, David Laibson, and Brigitte C. Madrian. "Planning Prompts as a Means of Increasing Preventive Screening Rates." Preventive Medicine 56, no. 1 (January 2013): 92–93.
- 15 Jun 2004
- Conference Presentation
What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study
By: William B. Simpson, Frances J. Hayes, Andre B. Araujo and John B. McKinlay
Keywords: Measurement and Metrics; Health Testing and Trials; Age Characteristics; Gender Characteristics; Massachusetts
Simpson, William B., Frances J. Hayes, Andre B. Araujo, and John B. McKinlay. "What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study." Paper presented at the Enocrine Society Annual Meeting, New Orleans, LA, June 15, 2004.
- April 2009 (Revised May 2010)
- Case
Partners In Health: HIV Care in Rwanda
By: Michael E. Porter, Scott S. Lee, Joseph Rhatigan and Jim Yong Kim
In 2005, Partners in Health (PIH) was invited by the Rwandan Ministry of Health to assume responsibility for the management of public health care in two rural districts in Eastern Rwanda and create an HIV treatment program at these sites. PIH successfully implemented a... View Details
Keywords: Developing Countries and Economies; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Service Delivery; Nonprofit Organizations; Expansion; Health Industry; Rwanda
Porter, Michael E., Scott S. Lee, Joseph Rhatigan, and Jim Yong Kim. "Partners In Health: HIV Care in Rwanda." Harvard Business School Case 709-474, April 2009. (Revised May 2010.)
- 03 Nov 2015
- First Look
November 3, 2015
at facilitating communication and collaboration between practitioners and academics by introducing key vocabulary and concepts used in rigorous impact evaluation methods,... View Details
Keywords: Sean Silverthorne
- 25 Mar 2013
- Research & Ideas
How Chapter 11 Saved the US Economy
the airline to work with the court to restructure and unload a significant amount of its debt, giving an iconic company "a second bite of the apple," says Gilson. An unabashed advocate of Chapter... View Details
- 24 Jul 2019
- Lessons from the Classroom
Can These Business Students Motivate Londoners to Do the Right Thing?
unintended consequences..." The approach has really taken hold in policy settings, and there are now many teams in governments focused on bringing behavioral insights and randomized controlled View Details
Keywords: by Dina Gerdeman
- October 2020 (Revised November 2023)
- Case
COVID-19 Testing at Everlywell
By: Jeffrey J. Bussgang and Olivia Hull
In March 2020, as COVID-19 spreads rapidly across the U.S., Everlywell founder Julia Cheek considers how to respond as a small start-up specializing in at-home lab testing. After making dramatic budget cuts, she decides to pivot the organization to address the... View Details
Keywords: Entrepreneurship; Business Strategy; Venture Capital; Health Care and Treatment; Health Disorders; Leading Change; Technology Adoption; Digital Platforms; Competitive Strategy; Science; Adaptation; Corporate Social Responsibility and Impact; Crisis Management; Social Entrepreneurship; Ethics; Government Legislation; Health; Health Testing and Trials; Health Pandemics; Consumer Products Industry; Health Industry; Technology Industry; Texas; United States
Bussgang, Jeffrey J., and Olivia Hull. "COVID-19 Testing at Everlywell." Harvard Business School Case 821-001, October 2020. (Revised November 2023.)
- 08 May 2012
- First Look
First Look: May 8
case updates events since the court's ruling against Myriad Genetics on March 29, 2010, and should be used in conjunction with "Gene Patents (A)." On July 29, 2011, a U.S. appeals court reversed... View Details
Keywords: Carmen Nobel
- 06 Feb 2006
- Research & Ideas
Sorting Out the Patent Craze
licensing royalties from memory manufacturers. The basis of this campaign—which a trial judge eventually described as "employing a combination of blitzkrieg and Sherman-esque tactics"—was a single... View Details
- 14 Nov 2019
- Book
Lifting the Lid on Turkey's Hidden Business History
it to wholly separate and autonomous agencies, supported by efficient and autonomous court systems. Sadly, the Turkish judiciary and police are... View Details
Keywords: by Sean Silverthorne
- November 2003 (Revised September 2008)
- Case
Circle Gastroenterology Products (A)
By: Regina E. Herzlinger and James Weber
A new, minimally invasive medical device has achieved only one-third of its budget. Was the problem one of marketing strategy, sales, reimbursement, and/or clinical trials? View Details
Keywords: Health Testing and Trials; Marketing Strategy; Product Marketing; Sales; Medical Devices and Supplies Industry
Herzlinger, Regina E., and James Weber. "Circle Gastroenterology Products (A)." Harvard Business School Case 304-052, November 2003. (Revised September 2008.)
- 06 Jan 2012
- Op-Ed
Where Green Corporate Ratings Fail
News Corporation—a multinational media conglomerate that includes BSKYB, Dow Jones, Fox News, 20th Century Fox and Star, among other units—announced earlier this year that it has become climate neutral, meaning that its operations have no net impact on global climate... View Details